Nuveen
INMB icon

Nuveen’s INmune Bio INMB Stock Holding History

Nuveen’s Portfolio INMB Stock Details INMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-16,518
Closed -$18.7K – 3796
2026
Q1 		$18.7K Hold
16,518
– – ﹤0.01% 3221
2025
Q4 		$25.8K Hold
16,518
– – ﹤0.01% 3244
2025
Q3 		$34.2K Hold
16,518
– – ﹤0.01% 3251
2025
Q2 		$38.2K Hold
16,518
– – ﹤0.01% 3270
2025
Q1 		$129K Hold
16,518
– – ﹤0.01% 3190
2024
Q4 		$77.1K Hold
16,518
– – ﹤0.01% 3303
2024
Q3 		$89K Hold
16,518
– – ﹤0.01% 3314
2024
Q2 		$146K Buy
+16,518
New +$163K ﹤0.01% 3273

Other funds holding INMB

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Nuveen's INMB Position: Q2 2026 in Review

Nuveen sold out of INmune Bio (INMB) in Q2 2026, closing a stake of 16,518 shares — an estimated $18.7K sold.

Nuveen first reported a position in INMB in Q2 2024 and held it in 8 quarters. The position peaked at $146K in Q2 2024. 83 funds tracked by Wall St. Rank hold INMB as of Q2 2026.

  • Nuveen reported no remaining INmune Bio position as of Q2 2026 after selling out during the quarter.
  • Nuveen sold 16,518 INmune Bio shares in Q2 2026, an estimated $18.7K.
  • Nuveen first reported a position in INmune Bio in Q2 2024 and held it in 8 quarters.
  • Nuveen's INmune Bio position peaked at $146K in Q2 2024.
  • 83 funds tracked by Wall St. Rank held INmune Bio as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.